Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Hope for China’s academic spinouts

How professors are joining China’s drive toward innovative biotech

Peking University spinout Hope Medicine is one of the latest examples of a trend that sees academics from Chinese universities increasingly taking top roles in a biotech sector traditionally led by MNC veterans.

The start-up launched early this month with a deal with Bayer AG (Xetra:BAYN),

Read the full 451 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers